nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A2—Metformin—polycystic ovary syndrome	0.314	0.535	CbGbCtD
Amantadine—SLC22A1—Metformin—polycystic ovary syndrome	0.273	0.465	CbGbCtD
Amantadine—GRIN2C—adrenal cortex—polycystic ovary syndrome	0.00639	0.0819	CbGeAlD
Amantadine—DDC—embryo—polycystic ovary syndrome	0.00503	0.0645	CbGeAlD
Amantadine—Hypothermia—Metformin—polycystic ovary syndrome	0.00473	0.0951	CcSEcCtD
Amantadine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00473	0.0951	CcSEcCtD
Amantadine—GRIN1—endocrine gland—polycystic ovary syndrome	0.00331	0.0425	CbGeAlD
Amantadine—GRIN2A—adrenal gland—polycystic ovary syndrome	0.00319	0.0409	CbGeAlD
Amantadine—GRIN2B—endocrine gland—polycystic ovary syndrome	0.00316	0.0405	CbGeAlD
Amantadine—DDC—adrenal gland—polycystic ovary syndrome	0.00298	0.0382	CbGeAlD
Amantadine—GRIN2A—vagina—polycystic ovary syndrome	0.00295	0.0379	CbGeAlD
Amantadine—GRIN2A—endocrine gland—polycystic ovary syndrome	0.00276	0.0354	CbGeAlD
Amantadine—MAOB—embryo—polycystic ovary syndrome	0.00259	0.0332	CbGeAlD
Amantadine—DDC—endocrine gland—polycystic ovary syndrome	0.00258	0.0331	CbGeAlD
Amantadine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00237	0.0477	CcSEcCtD
Amantadine—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.00222	0.0284	CbGeAlD
Amantadine—MAOB—adrenal cortex—polycystic ovary syndrome	0.00212	0.0272	CbGeAlD
Amantadine—SIGMAR1—endometrium—polycystic ovary syndrome	0.00198	0.0254	CbGeAlD
Amantadine—Lethargy—Metformin—polycystic ovary syndrome	0.00196	0.0395	CcSEcCtD
Amantadine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00193	0.0248	CbGeAlD
Amantadine—MAOB—endometrium—polycystic ovary syndrome	0.00189	0.0243	CbGeAlD
Amantadine—SIGMAR1—uterus—polycystic ovary syndrome	0.00182	0.0234	CbGeAlD
Amantadine—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.00179	0.023	CbGeAlD
Amantadine—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.00178	0.0229	CbGeAlD
Amantadine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00178	0.0357	CcSEcCtD
Amantadine—MAOB—uterus—polycystic ovary syndrome	0.00175	0.0224	CbGeAlD
Amantadine—MAOB—pituitary gland—polycystic ovary syndrome	0.00171	0.022	CbGeAlD
Amantadine—MAOB—adipose tissue—polycystic ovary syndrome	0.00171	0.0219	CbGeAlD
Amantadine—Sweating increased—Metformin—polycystic ovary syndrome	0.00162	0.0326	CcSEcCtD
Amantadine—SLC22A1—vagina—polycystic ovary syndrome	0.00161	0.0206	CbGeAlD
Amantadine—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.0016	0.0205	CbGeAlD
Amantadine—Neutropenia—Metformin—polycystic ovary syndrome	0.00156	0.0313	CcSEcCtD
Amantadine—MAOB—adrenal gland—polycystic ovary syndrome	0.00153	0.0196	CbGeAlD
Amantadine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.0015	0.0193	CbGeAlD
Amantadine—SIGMAR1—female gonad—polycystic ovary syndrome	0.00149	0.0191	CbGeAlD
Amantadine—SIGMAR1—vagina—polycystic ovary syndrome	0.00148	0.019	CbGeAlD
Amantadine—DRD2—pituitary gland—polycystic ovary syndrome	0.00145	0.0186	CbGeAlD
Amantadine—MAOB—female gonad—polycystic ovary syndrome	0.00143	0.0183	CbGeAlD
Amantadine—MAOB—vagina—polycystic ovary syndrome	0.00142	0.0182	CbGeAlD
Amantadine—MAOB—endocrine gland—polycystic ovary syndrome	0.00133	0.017	CbGeAlD
Amantadine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00131	0.0264	CcSEcCtD
Amantadine—Eye disorder—Metformin—polycystic ovary syndrome	0.00124	0.025	CcSEcCtD
Amantadine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00124	0.0248	CcSEcCtD
Amantadine—Angiopathy—Metformin—polycystic ovary syndrome	0.00121	0.0243	CcSEcCtD
Amantadine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0012	0.0241	CcSEcCtD
Amantadine—Malnutrition—Metformin—polycystic ovary syndrome	0.00116	0.0233	CcSEcCtD
Amantadine—DRD2—endocrine gland—polycystic ovary syndrome	0.00112	0.0144	CbGeAlD
Amantadine—Vision blurred—Metformin—polycystic ovary syndrome	0.00109	0.022	CcSEcCtD
Amantadine—Tremor—Metformin—polycystic ovary syndrome	0.00109	0.0218	CcSEcCtD
Amantadine—Palpitations—Metformin—polycystic ovary syndrome	0.00102	0.0206	CcSEcCtD
Amantadine—Hypertension—Metformin—polycystic ovary syndrome	0.001	0.0201	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00098	0.0197	CcSEcCtD
Amantadine—Oedema—Metformin—polycystic ovary syndrome	0.000946	0.019	CcSEcCtD
Amantadine—ABCB1—embryo—polycystic ovary syndrome	0.000944	0.0121	CbGeAlD
Amantadine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000927	0.0186	CcSEcCtD
Amantadine—Skin disorder—Metformin—polycystic ovary syndrome	0.000919	0.0185	CcSEcCtD
Amantadine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000914	0.0184	CcSEcCtD
Amantadine—Anorexia—Metformin—polycystic ovary syndrome	0.000901	0.0181	CcSEcCtD
Amantadine—Hypotension—Metformin—polycystic ovary syndrome	0.000884	0.0178	CcSEcCtD
Amantadine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000849	0.0171	CcSEcCtD
Amantadine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000843	0.0169	CcSEcCtD
Amantadine—Somnolence—Metformin—polycystic ovary syndrome	0.000841	0.0169	CcSEcCtD
Amantadine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000832	0.0167	CcSEcCtD
Amantadine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000822	0.0165	CcSEcCtD
Amantadine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000816	0.0164	CcSEcCtD
Amantadine—Fatigue—Metformin—polycystic ovary syndrome	0.000815	0.0164	CcSEcCtD
Amantadine—Constipation—Metformin—polycystic ovary syndrome	0.000809	0.0163	CcSEcCtD
Amantadine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000779	0.0157	CcSEcCtD
Amantadine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000774	0.00992	CbGeAlD
Amantadine—ABCB1—endometrium—polycystic ovary syndrome	0.000691	0.00886	CbGeAlD
Amantadine—Asthenia—Metformin—polycystic ovary syndrome	0.000679	0.0136	CcSEcCtD
Amantadine—Pruritus—Metformin—polycystic ovary syndrome	0.000669	0.0134	CcSEcCtD
Amantadine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000647	0.013	CcSEcCtD
Amantadine—ABCB1—uterus—polycystic ovary syndrome	0.000637	0.00817	CbGeAlD
Amantadine—Dizziness—Metformin—polycystic ovary syndrome	0.000625	0.0126	CcSEcCtD
Amantadine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000625	0.00802	CbGeAlD
Amantadine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000623	0.00799	CbGeAlD
Amantadine—Vomiting—Metformin—polycystic ovary syndrome	0.000601	0.0121	CcSEcCtD
Amantadine—Rash—Metformin—polycystic ovary syndrome	0.000596	0.012	CcSEcCtD
Amantadine—Dermatitis—Metformin—polycystic ovary syndrome	0.000596	0.012	CcSEcCtD
Amantadine—Headache—Metformin—polycystic ovary syndrome	0.000592	0.0119	CcSEcCtD
Amantadine—Nausea—Metformin—polycystic ovary syndrome	0.000562	0.0113	CcSEcCtD
Amantadine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000559	0.00716	CbGeAlD
Amantadine—ABCB1—female gonad—polycystic ovary syndrome	0.000521	0.00668	CbGeAlD
Amantadine—ABCB1—vagina—polycystic ovary syndrome	0.000518	0.00664	CbGeAlD
Amantadine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000484	0.00621	CbGeAlD
Amantadine—DDC—Metabolism—SULT2A1—polycystic ovary syndrome	0.000107	0.000373	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—LEP—polycystic ovary syndrome	0.000105	0.000368	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000104	0.000365	CbGpPWpGaD
Amantadine—DDC—Metabolism—RRM2—polycystic ovary syndrome	0.000103	0.000361	CbGpPWpGaD
Amantadine—MAOB—Metabolism—LHB—polycystic ovary syndrome	0.000103	0.000361	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—LEP—polycystic ovary syndrome	0.000102	0.000358	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000102	0.000357	CbGpPWpGaD
Amantadine—MAOB—Metabolism—HSD3B2—polycystic ovary syndrome	0.000101	0.000352	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0001	0.000351	CbGpPWpGaD
Amantadine—DDC—Metabolism—YAP1—polycystic ovary syndrome	9.96e-05	0.000348	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—LEP—polycystic ovary syndrome	9.9e-05	0.000346	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	9.86e-05	0.000345	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKR1C1—polycystic ovary syndrome	9.76e-05	0.000341	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	9.74e-05	0.000341	CbGpPWpGaD
Amantadine—DDC—Metabolism—NAMPT—polycystic ovary syndrome	9.57e-05	0.000335	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	9.56e-05	0.000334	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	9.5e-05	0.000332	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	9.48e-05	0.000332	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP11A1—polycystic ovary syndrome	9.45e-05	0.000331	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—IL6—polycystic ovary syndrome	9.37e-05	0.000328	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKR1C2—polycystic ovary syndrome	9.31e-05	0.000326	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TEAD2—polycystic ovary syndrome	9.31e-05	0.000326	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—PPARG—polycystic ovary syndrome	9.15e-05	0.00032	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SULT2A1—polycystic ovary syndrome	8.98e-05	0.000314	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—INS—polycystic ovary syndrome	8.98e-05	0.000314	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKR1C3—polycystic ovary syndrome	8.92e-05	0.000312	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—PPARG—polycystic ovary syndrome	8.92e-05	0.000312	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	8.87e-05	0.00031	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GHRL—polycystic ovary syndrome	8.79e-05	0.000307	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP17A1—polycystic ovary syndrome	8.78e-05	0.000307	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—INS—polycystic ovary syndrome	8.75e-05	0.000306	CbGpPWpGaD
Amantadine—MAOB—Metabolism—RRM2—polycystic ovary syndrome	8.7e-05	0.000304	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FLT4—polycystic ovary syndrome	8.69e-05	0.000304	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	8.68e-05	0.000303	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	8.68e-05	0.000303	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT2—polycystic ovary syndrome	8.68e-05	0.000303	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	8.65e-05	0.000303	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	8.62e-05	0.000302	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—PPARG—polycystic ovary syndrome	8.62e-05	0.000302	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT2—polycystic ovary syndrome	8.46e-05	0.000296	CbGpPWpGaD
Amantadine—MAOB—Metabolism—YAP1—polycystic ovary syndrome	8.38e-05	0.000293	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	8.29e-05	0.00029	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	8.06e-05	0.000282	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NAMPT—polycystic ovary syndrome	8.05e-05	0.000282	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP11A1—polycystic ovary syndrome	7.95e-05	0.000278	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—VEGFA—polycystic ovary syndrome	7.95e-05	0.000278	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	7.91e-05	0.000277	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.85e-05	0.000275	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	7.8e-05	0.000273	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	7.77e-05	0.000272	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—VEGFA—polycystic ovary syndrome	7.75e-05	0.000271	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.73e-05	0.00027	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.71e-05	0.00027	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	7.61e-05	0.000266	CbGpPWpGaD
Amantadine—DDC—Metabolism—TH—polycystic ovary syndrome	7.6e-05	0.000266	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPB—polycystic ovary syndrome	7.6e-05	0.000266	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	7.56e-05	0.000264	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—LHB—polycystic ovary syndrome	7.52e-05	0.000263	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKR1C3—polycystic ovary syndrome	7.51e-05	0.000263	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	7.5e-05	0.000262	CbGpPWpGaD
Amantadine—DDC—Metabolism—SLC2A4—polycystic ovary syndrome	7.39e-05	0.000259	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP17A1—polycystic ovary syndrome	7.39e-05	0.000259	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	7.39e-05	0.000259	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	7.35e-05	0.000257	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	7.28e-05	0.000255	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	7.27e-05	0.000254	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.19e-05	0.000251	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	7.18e-05	0.000251	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	7.05e-05	0.000247	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.05e-05	0.000247	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—SCT—polycystic ovary syndrome	7.05e-05	0.000247	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	7.03e-05	0.000246	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	6.98e-05	0.000244	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP19A1—polycystic ovary syndrome	6.95e-05	0.000243	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.91e-05	0.000242	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	6.89e-05	0.000241	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.87e-05	0.00024	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—LHB—polycystic ovary syndrome	6.83e-05	0.000239	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.75e-05	0.000236	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.73e-05	0.000235	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.68e-05	0.000234	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	6.57e-05	0.00023	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.57e-05	0.00023	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	6.43e-05	0.000225	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	6.43e-05	0.000225	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	6.4e-05	0.000224	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TH—polycystic ovary syndrome	6.4e-05	0.000224	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.34e-05	0.000222	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.34e-05	0.000222	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	6.29e-05	0.00022	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SLC2A4—polycystic ovary syndrome	6.22e-05	0.000218	CbGpPWpGaD
Amantadine—DDC—Metabolism—GNAS—polycystic ovary syndrome	6.21e-05	0.000217	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	6.11e-05	0.000214	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	6e-05	0.00021	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	5.98e-05	0.000209	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.97e-05	0.000209	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.93e-05	0.000207	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.92e-05	0.000207	CbGpPWpGaD
Amantadine—DDC—Metabolism—NCOR1—polycystic ovary syndrome	5.91e-05	0.000207	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	5.86e-05	0.000205	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP19A1—polycystic ovary syndrome	5.85e-05	0.000205	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.76e-05	0.000201	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—VEGFA—polycystic ovary syndrome	5.67e-05	0.000198	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP1A1—polycystic ovary syndrome	5.6e-05	0.000196	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.6e-05	0.000196	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	5.59e-05	0.000196	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—VEGFA—polycystic ovary syndrome	5.53e-05	0.000193	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.52e-05	0.000193	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—polycystic ovary syndrome	5.5e-05	0.000192	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	5.47e-05	0.000191	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	5.46e-05	0.000191	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—polycystic ovary syndrome	5.36e-05	0.000187	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	5.35e-05	0.000187	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	5.27e-05	0.000184	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—polycystic ovary syndrome	5.22e-05	0.000183	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GNAS—polycystic ovary syndrome	5.22e-05	0.000183	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	5.18e-05	0.000181	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	5.1e-05	0.000178	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.09e-05	0.000178	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	5.08e-05	0.000178	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	5.08e-05	0.000178	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	4.98e-05	0.000174	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NCOR1—polycystic ovary syndrome	4.98e-05	0.000174	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.97e-05	0.000174	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	4.83e-05	0.000169	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.76e-05	0.000167	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP1A1—polycystic ovary syndrome	4.72e-05	0.000165	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	4.64e-05	0.000162	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	4.61e-05	0.000161	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.6e-05	0.000161	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	4.54e-05	0.000159	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.53e-05	0.000158	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.51e-05	0.000158	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	4.45e-05	0.000156	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	4.44e-05	0.000155	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—polycystic ovary syndrome	4.4e-05	0.000154	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.36e-05	0.000153	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	4.3e-05	0.00015	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	4.27e-05	0.00015	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	4.26e-05	0.000149	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.24e-05	0.000148	CbGpPWpGaD
Amantadine—DDC—Metabolism—PPARG—polycystic ovary syndrome	4.24e-05	0.000148	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.22e-05	0.000148	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.21e-05	0.000147	CbGpPWpGaD
Amantadine—DDC—Metabolism—POMC—polycystic ovary syndrome	4.18e-05	0.000146	CbGpPWpGaD
Amantadine—DDC—Metabolism—INS—polycystic ovary syndrome	4.16e-05	0.000145	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	4.15e-05	0.000145	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	4.14e-05	0.000145	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.11e-05	0.000144	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.08e-05	0.000143	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	4.04e-05	0.000141	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	4.04e-05	0.000141	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.99e-05	0.000139	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	3.98e-05	0.000139	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.95e-05	0.000138	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.93e-05	0.000138	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.92e-05	0.000137	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—polycystic ovary syndrome	3.92e-05	0.000137	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.85e-05	0.000135	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.85e-05	0.000135	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—polycystic ovary syndrome	3.82e-05	0.000134	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.82e-05	0.000134	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.81e-05	0.000133	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	3.78e-05	0.000132	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.73e-05	0.000131	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.72e-05	0.00013	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	3.69e-05	0.000129	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.66e-05	0.000128	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.61e-05	0.000126	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPARG—polycystic ovary syndrome	3.57e-05	0.000125	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	3.55e-05	0.000124	CbGpPWpGaD
Amantadine—MAOB—Metabolism—POMC—polycystic ovary syndrome	3.52e-05	0.000123	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	3.52e-05	0.000123	CbGpPWpGaD
Amantadine—MAOB—Metabolism—INS—polycystic ovary syndrome	3.5e-05	0.000122	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.46e-05	0.000121	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.44e-05	0.00012	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	3.43e-05	0.00012	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	3.4e-05	0.000119	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.3e-05	0.000116	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.28e-05	0.000115	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	3.28e-05	0.000115	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.24e-05	0.000113	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.23e-05	0.000113	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	3.16e-05	0.000111	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.11e-05	0.000109	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	3.1e-05	0.000108	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.08e-05	0.000108	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.99e-05	0.000105	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.94e-05	0.000103	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.92e-05	0.000102	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.9e-05	0.000101	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.89e-05	0.000101	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	2.87e-05	0.0001	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.83e-05	9.89e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	2.77e-05	9.7e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.66e-05	9.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.66e-05	9.32e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	2.64e-05	9.24e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.6e-05	9.11e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	2.58e-05	9.04e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.57e-05	8.98e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.54e-05	8.89e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.52e-05	8.82e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.5e-05	8.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.48e-05	8.67e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.47e-05	8.63e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	2.46e-05	8.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.43e-05	8.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.35e-05	8.21e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.33e-05	8.17e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	2.33e-05	8.16e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.33e-05	8.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.33e-05	8.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	2.33e-05	8.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.31e-05	8.07e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.24e-05	7.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.21e-05	7.72e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.18e-05	7.62e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	2.17e-05	7.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.14e-05	7.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.05e-05	7.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.95e-05	6.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.91e-05	6.69e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.89e-05	6.62e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.87e-05	6.53e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.86e-05	6.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.85e-05	6.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.8e-05	6.31e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	1.76e-05	6.17e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	1.74e-05	6.08e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	1.73e-05	6.05e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.7e-05	5.93e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.64e-05	5.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	1.6e-05	5.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.51e-05	5.3e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.44e-05	5.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.43e-05	5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	1.38e-05	4.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	1.37e-05	4.79e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.37e-05	4.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.32e-05	4.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.32e-05	4.63e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.27e-05	4.46e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.26e-05	4.4e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.03e-05	3.62e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.02e-05	3.57e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.01e-05	3.55e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.01e-05	3.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.65e-06	3.03e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	5.98e-06	2.09e-05	CbGpPWpGaD
